Gene · 476
Papers2,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers. | Int J Mol Sci | 2022 | 36232400 | PubTator, text mining | PubMed |
| Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation. | Cells | 2022 | 36231068 | PubTator, text mining | PubMed |
| Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation. | Cell Rep Med | 2022 | 36223777 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Marker-free co-selection for successive rounds of prime editing in human cells. | Nat Commun | 2022 | 36207338 | PubTator, text mining | PubMed |
| Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance. | Front Genet | 2022 | 36204307 | PubTator, text mining | PubMed |
| GJB2 and GJB6 gene transcripts in the human cochlea: A study using RNAscope, confocal, and super-resolution structured illumination microscopy. | Front Mol Neurosci | 2022 | 36204137 | PubTator, text mining | PubMed |
| Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer. | Front Immunol | 2022 | 36189312 | PubTator, text mining | PubMed |
| Long-term osteogenic differentiation of human bone marrow stromal cells in simulated microgravity: novel proteins sighted. | Cell Mol Life Sci | 2022 | 36181557 | PubTator, text mining | PubMed |
| Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. | Front Cardiovasc Med | 2022 | 36172573 | PubTator, text mining | PubMed |
| The phospholipid flippase ATP8B1 is required for lysosomal fusion in macrophages. | Cell Biochem Funct | 2022 | 36169099 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification. | Front Oncol | 2022 | 36158681 | PubTator, text mining | PubMed |
| Evaluation of the Fecal Proteome in Healthy and Diseased Cheetahs (Acinonyx jubatus) Suffering from Gastrointestinal Disorders. | Animals (Basel) | 2022 | 36139251 | PubTator, text mining | PubMed |
| FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ. | Sci Adv | 2022 | 36129980 | PubTator, text mining | PubMed |
| Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery. | Sci Adv | 2022 | 36129975 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Disorders of the adrenal cortex: Genetic and molecular aspects. | Front Endocrinol (Lausanne) | 2022 | 36105398 | PubTator, text mining | PubMed |
| The history of small extracellular vesicles and their implication in cancer drug resistance. | Front Oncol | 2022 | 36091133 | PubTator, text mining | PubMed |
| Structure and function of H+/K+ pump mutants reveal Na+/K+ pump mechanisms. | Nat Commun | 2022 | 36085139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/476/papers?page=19